Frontlight ResearchEarly access
Chronic myeloid leukaemia trials, also abroad
190 open Chronic myeloid leukaemia trials worldwide. Travel and costs are your own unless the study pays them; ask the study team first.
The same trial often runs in several countries
Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Tuspetinib (HM43239) in Patients With Relapsed or Refractory Acute Myeloid Leukemia has 1 site in Sweden and runs in 8 countries. If a site near you is full, another one may still take people.
See Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Tuspetinib (HM43239) in Patients With Relapsed or Refractory Acute Myeloid Leukemia in all 8 countries